Xencor, Inc. (XNCR) Financials

XNCR Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 725.0 million 221.7 million
March 31, 2026 736.8 million 221.2 million
Dec. 31, 2025 875.5 million 239.9 million
Sept. 30, 2025 868.8 million 243.5 million

XNCR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -124.4 million 18.8 million
March 31, 2026 -68.2 million 9.6 million
Dec. 31, 2025 -52.9 million 10.2 million
Sept. 30, 2025 -31.0 million 10.1 million

XNCR Net Income

No data available :(

XNCR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 456.5 million - 65.2 million
March 31, 2026 445.0 million 82.1 million 66.6 million
Dec. 31, 2025 547.7 million 76.5 million 68.0 million
Sept. 30, 2025 471.0 million 87.8 million 69.3 million

XNCR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 75.9 million
March 31, 2026 75.2 million
Dec. 31, 2025 74.2 million
Sept. 30, 2025 74.4 million

XNCR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 1.1 million 71.9 million 16.4 million -
March 31, 2026 610000 64.7 million 17.7 million -
Dec. 31, 2025 1.1 million 64.8 million 17.0 million -
Sept. 30, 2025 183000 54.4 million 14.2 million -

XNCR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 51.2 million -
March 31, 2026 4.5 million 2.6 million
Dec. 31, 2025 28.2 million 2.6 million
Sept. 30, 2025 21.0 million 54.4 million

XNCR Revenue by Segment
Graph available only for paid members. Upgrade to see it.

XNCR

Price: $23.34

52 week price:
6.92
23.34

Earnings Per Share: -2.16 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 500400

Ebitda: -14.8 million

Market Capitalization: 1.6 billion

Links: